These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33428808)

  • 41. Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.
    Hayakawa F; Sakura T; Yujiri T; Kondo E; Fujimaki K; Sasaki O; Miyatake J; Handa H; Ueda Y; Aoyama Y; Takada S; Tanaka Y; Usui N; Miyawaki S; Suenobu S; Horibe K; Kiyoi H; Ohnishi K; Miyazaki Y; Ohtake S; Kobayashi Y; Matsuo K; Naoe T;
    Blood Cancer J; 2014 Oct; 4(10):e252. PubMed ID: 25325302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period.
    Utuama O; Mukhtar F; Pham YT; Dabo B; Manani P; Moser J; Michael-Asalu A; Tran CT; Le LC; Le TV; Vu KT; Park JY; Boffetta P; Zheng W; Shu XO; Luu HN
    PLoS One; 2019; 14(8):e0220864. PubMed ID: 31425527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
    Hunger SP; Lu X; Devidas M; Camitta BM; Gaynon PS; Winick NJ; Reaman GH; Carroll WL
    J Clin Oncol; 2012 May; 30(14):1663-9. PubMed ID: 22412151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute myeloid leukemia in adolescents and young adults: challenging aspects.
    Ofran Y; Rowe JM
    Acta Haematol; 2014; 132(3-4):292-7. PubMed ID: 25228554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009.
    Bailey C; Richardson LC; Allemani C; Bonaventure A; Harewood R; Moore AR; Stewart SL; Weir HK; Coleman MP;
    Cancer; 2018 Oct; 124(19):3856-3867. PubMed ID: 30343495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors.
    Sasaki K; Kantarjian HM; Jain P; Jabbour EJ; Ravandi F; Konopleva M; Borthakur G; Takahashi K; Pemmaraju N; Daver N; Pierce SA; O'Brien SM; Cortes JE
    Cancer; 2016 Jan; 122(2):238-48. PubMed ID: 26479889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.
    Liu L; Moke DJ; Tsai KY; Hwang A; Freyer DR; Hamilton AS; Zhang J; Cockburn M; Deapen D
    J Natl Cancer Inst; 2019 May; 111(5):509-518. PubMed ID: 30321398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute leukemias in Piauí: comparison with features observed in other regions of Brazil.
    Rego MF; Pinheiro GS; Metze K; Lorand-Metze I
    Braz J Med Biol Res; 2003 Mar; 36(3):331-7. PubMed ID: 12640497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
    Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
    Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-center experience suggests donor lymphocyte infusion may promote long-term survival in children with high-risk acute lymphoblastic leukemia.
    Liberio N; Robinson H; Nugent M; Simpson P; Margolis DA; Malarkannan S; Keever-Taylor C; Thakar MS
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27950. PubMed ID: 31368194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival Outcome of Alternative Medicine Treatment for Newly Diagnosed Acute Leukemia in Children.
    Chotsampancharoen T; Sripornsawan P; Duangchu S; Wongchanchailert M; McNeil E
    Acta Haematol; 2018; 140(4):203-208. PubMed ID: 30343295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
    Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
    Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of children with chronic myeloid leukemia: A population-based cohort study.
    Egan G; Athale U; Johnston D; Pole JD; Silva M; Zorzi A; Alexander S
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28491. PubMed ID: 32589368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study.
    Bencomo-Alvarez AE; Gonzalez MA; Rubio AJ; Olivas IM; Lara JJ; Padilla O; Orazi A; Corral J; Philipovskiy A; Gaur S; Mulla ZD; Dwivedi AK; Eiring AM
    Cancer; 2021 Apr; 127(7):1068-1079. PubMed ID: 33616915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Report of an international expanded access program of imatinib in adults with Philadelphia chromosome positive leukemias.
    Capdeville R; Krahnke T; Hatfield A; Ford JM; Van Hoomissen I; Gathmann I
    Ann Oncol; 2008 Jul; 19(7):1320-1326. PubMed ID: 18344535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Descriptive epidemiology of myeloid leukemia].
    Matsuo K; Ito H
    Nihon Rinsho; 2009 Oct; 67(10):1847-51. PubMed ID: 19860178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013.
    Beinortas T; Tavorienė I; Žvirblis T; Gerbutavičius R; Jurgutis M; Griškevičius L
    BMC Cancer; 2016 Mar; 16():198. PubMed ID: 26956037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fms-like tyrosine kinase 3 mutations in childhood acute leukemias and their association with prognosis.
    Karabacak BH; Erbey F; Bayram I; Yilmaz S; Acipayam C; Kilinç Y; Tanyeli A
    Asian Pac J Cancer Prev; 2010; 11(4):923-7. PubMed ID: 21133602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.
    Höglund M; Sandin F; Hellström K; Björeman M; Björkholm M; Brune M; Dreimane A; Ekblom M; Lehmann S; Ljungman P; Malm C; Markevärn B; Myhr-Eriksson K; Ohm L; Olsson-Strömberg U; Själander A; Wadenvik H; Simonsson B; Stenke L; Richter J
    Blood; 2013 Aug; 122(7):1284-92. PubMed ID: 23843494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.